netFormulary
 Report : A-Z HCD items in Formulary 07/04/2020 23:26:22
[Back]
 
Section Status CCG Name
04.12 Formulary CCG Botulinum neurotoxin type A Xeomin
10.01.03 Restricted Use CCG Brodalumab Kyntheum
08.01.05 Formulary CCG Dupilumab 
06.01.02.03 Formulary CCG Ertugliflozin  Steglatro
10.01.03 Restricted Use CCG Golimumab Simponi
13.05.03 Formulary CCG Guselkumab Tremfya
13.05.03 Formulary CCG Ixekizumab Taltz
09.01.04 Formulary CCG Lusutrombopag Mulpleo
09.02.01.01 Formulary CCG Patiromer  Veltassa
07.04.03 Formulary CCG Pentosan polysulfate elmiron
13.05.02 Formulary CCG Risankizumab 
03.03.03 Formulary CCG Roflumilast Daxas
09.02.01.01 Formulary CCG Sodium zirconium cyclosilicate Lokelma
06.01.02.03 Formulary CCG Sotagliflozin 
13.05.03 Formulary CCG Tildrakizumab 
01.05.03 Formulary CCG Tofacitinib Xeljanz
10.02.01 Formulary CCG Tofacitinib Xeljanz
Birmingham, Sandwell, Solihull and environs APC Formulary